138 results
Page 2 of 7
8-K
EX-1.1
mh8vbk
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
424B5
nrhbb1
14 Sep 22
Prospectus supplement for primary offering
4:12pm
424B5
5vtcet1qsl2c0con
13 Sep 22
Prospectus supplement for primary offering
5:19pm
8-K
EX-99.2
l51f5 kjjpkdt
12 Sep 22
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
7:54am
S-8
EX-23.2
fcqe orfjk36r
12 Aug 22
Registration of securities for employees
8:23am
424B3
f7n3zlp5wyuja
11 Jul 22
Prospectus supplement
4:32pm
POS AM
8x72xri
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
POS AM
EX-23.1
mjtz40uolt3j utjcpz
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
S-3
EX-4.7
78sfl7i
1 Jul 22
Shelf registration
4:13pm
S-3
EX-5.1
lya57
1 Jul 22
Shelf registration
4:13pm
S-3
j6lpxw k05leoc
1 Jul 22
Shelf registration
4:13pm
S-3
EX-23.1
6q3nd1bk
1 Jul 22
Shelf registration
4:13pm
S-3
EX-4.6
9k3xkh icpg
1 Jul 22
Shelf registration
4:13pm
S-3
EX-1.2
poiiok4w
1 Jul 22
Shelf registration
4:13pm
8-K
4ohj0kcw43022w
3 Jun 22
Submission of Matters to a Vote of Security Holders
1:21pm
DEF 14A
w7t h44fenu49c
28 Apr 22
Definitive proxy
8:36am
424B3
8c1r 96cbs0lqs49
31 Mar 22
Prospectus supplement
11:42am
POS AM
EX-23.1
j55 76z2toun3oq46i
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
POS AM
f66ip54g
25 Mar 22
Prospectus update (post-effective amendment)
8:41am